SANGINITA Stock Overview
Sanginita Chemicals Limited manufactures and exports cuprous chloride, cupric chloride, and copper sulphate in India.
Sanginita Chemicals Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₹20.00|
|52 Week High||₹47.20|
|52 Week Low||₹17.75|
|1 Month Change||-2.20%|
|3 Month Change||-8.88%|
|1 Year Change||-11.89%|
|3 Year Change||-68.99%|
|5 Year Change||n/a|
|Change since IPO||-61.91%|
Recent News & Updates
We Think Sanginita Chemicals (NSE:SANGINITA) Is Taking Some Risk With Its Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
|SANGINITA||IN Chemicals||IN Market|
Return vs Industry: SANGINITA underperformed the Indian Chemicals industry which returned -2.6% over the past year.
Return vs Market: SANGINITA underperformed the Indian Market which returned -1.7% over the past year.
|SANGINITA Average Weekly Movement||8.6%|
|Chemicals Industry Average Movement||6.8%|
|Market Average Movement||6.9%|
|10% most volatile stocks in IN Market||9.8%|
|10% least volatile stocks in IN Market||4.5%|
Stable Share Price: SANGINITA is more volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: SANGINITA's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
Sanginita Chemicals Limited manufactures and exports cuprous chloride, cupric chloride, and copper sulphate in India. The company also offers copper phthalocyanine blue crude. Its products are used in dyes and pigment industries, paint industries, pharmaceuticals industries, electroplating industries, metal extraction industries and ink, carbon paper, PVC pipe coating industries, etc. Sanginita Chemicals Limited was incorporated in 2005 and is headquartered in Gandhinagar, India.
Sanginita Chemicals Fundamentals Summary
|SANGINITA fundamental statistics|
Is SANGINITA overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SANGINITA income statement (TTM)|
|Cost of Revenue||₹1.91b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||0.20|
|Net Profit Margin||0.18%|
How did SANGINITA perform over the long term?See historical performance and comparison
Is SANGINITA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 0/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SANGINITA?
Other financial metrics that can be useful for relative valuation.
|What is SANGINITA's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does SANGINITA's PE Ratio compare to its peers?
|SANGINITA PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
Price-To-Earnings vs Peers: SANGINITA is expensive based on its Price-To-Earnings Ratio (99.2x) compared to the peer average (11x).
Price to Earnings Ratio vs Industry
How does SANGINITA's PE Ratio compare vs other companies in the Indian Chemicals Industry?
Price-To-Earnings vs Industry: SANGINITA is expensive based on its Price-To-Earnings Ratio (99.2x) compared to the Indian Chemicals industry average (16.8x)
Price to Earnings Ratio vs Fair Ratio
What is SANGINITA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||99.2x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SANGINITA's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of SANGINITA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate SANGINITA's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate SANGINITA's fair value for valuation analysis.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SANGINITA's PEG Ratio to determine if it is good value.
Discover undervalued companies
How is Sanginita Chemicals forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Materials industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sanginita Chemicals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Take a look at our analysis of SANGINITA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Sanginita Chemicals competitive advantages and company strategy can generally be found in its financial reports archived here.
How has Sanginita Chemicals performed over the past 5 years?
Past Performance Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SANGINITA has high quality earnings.
Growing Profit Margin: SANGINITA's current net profit margins (0.2%) are lower than last year (0.5%).
Past Earnings Growth Analysis
Earnings Trend: SANGINITA's earnings have declined by 23.9% per year over the past 5 years.
Accelerating Growth: SANGINITA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SANGINITA had negative earnings growth (-54.4%) over the past year, making it difficult to compare to the Chemicals industry average (29.6%).
Return on Equity
High ROE: SANGINITA's Return on Equity (0.9%) is considered low.
Discover strong past performing companies
How is Sanginita Chemicals's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: SANGINITA's short term assets (₹748.6M) exceed its short term liabilities (₹358.9M).
Long Term Liabilities: SANGINITA's short term assets (₹748.6M) exceed its long term liabilities (₹35.9M).
Debt to Equity History and Analysis
Debt Level: SANGINITA's net debt to equity ratio (86.9%) is considered high.
Reducing Debt: SANGINITA's debt to equity ratio has reduced from 92.2% to 86.9% over the past 5 years.
Debt Coverage: SANGINITA's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: SANGINITA's interest payments on its debt are not well covered by EBIT (1.2x coverage).
Discover healthy companies
What is Sanginita Chemicals's current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SANGINITA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SANGINITA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SANGINITA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SANGINITA's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SANGINITA has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Dineshsinh Chavada (62 yo)
Mr. Dineshsinh Bhimsinh Chavada has been Managing Director of Sanginita Chemicals Limited since November 23, 2016 and has been its Executive Director since January 1, 2007. Mr. Chavada has many years of ex...
CEO Compensation Analysis
Compensation vs Market: Dineshsinh's total compensation ($USD7.68K) is below average for companies of similar size in the Indian market ($USD38.35K).
Compensation vs Earnings: Dineshsinh's compensation has been consistent with company performance over the past year.
Experienced Management: SANGINITA's management team is seasoned and experienced (5.6 years average tenure).
Experienced Board: SANGINITA's board of directors are seasoned and experienced ( 10.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: SANGINITA insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Sanginita Chemicals Limited's employee growth, exchange listings and data sources
- Name: Sanginita Chemicals Limited
- Ticker: SANGINITA
- Exchange: NSEI
- Founded: 2005
- Industry: Commodity Chemicals
- Sector: Materials
- Implied Market Cap: ₹345.354m
- Shares outstanding: 17.27m
- Website: https://www.sanginitachemicals.co.in
Number of Employees
- Sanginita Chemicals Limited
- 301, Shalin Complex
- 3rd Floor
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/24 00:00|
|End of Day Share Price||2022/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.